Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Getinge AB's Enterprise Value is kr71,827 Mil.
Getinge AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was kr4,483 Mil. Therefore, Getinge AB's EV-to-EBIT ratio for today is 16.02.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Getinge AB's Enterprise Value is kr71,827 Mil.
Getinge AB's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was kr6,641 Mil. Therefore, Getinge AB's EV-to-EBITDA ratio for today is 10.82.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Getinge AB's Enterprise Value is kr71,827 Mil.
Getinge AB's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 was kr34,236 Mil. Therefore, Getinge AB's EV-to-Revenue ratio for today is 2.10.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Getinge AB's Enterprise Value is kr71,827 Mil.
Getinge AB's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was kr3,804 Mil. Therefore, Getinge AB's EV-to-FCF ratio for today is 18.88.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Getinge AB (OSTO:GETI B) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Getinge AB's current Enterprise Value is kr71,827 Mil.
Getinge AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr4,483 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Getinge AB's current Enterprise Value is kr71,827 Mil.
Getinge AB's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr6,641 Mil.
Getinge AB's current Enterprise Value is kr71,827 Mil.
Getinge AB's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr34,236 Mil.
Getinge AB's current Enterprise Value is kr71,827 Mil.
Getinge AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr5,035 Mil.
Getinge AB's current Enterprise Value is kr71,827 Mil.
Getinge AB's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3,804 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Getinge AB Enterprise Value Related Terms
Getinge AB Enterprise Value Historical Data
* Premium members only.
The historical data trend for Getinge AB's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:GETI B vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, Getinge AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Getinge AB Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Getinge AB's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Getinge AB's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of kr71,827 Mil mean?
Getinge AB (OSTO:GETI B) has a Enterprise Value of kr71,827 Mil as of Jul. 27, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Getinge AB and its competitors.
Is Getinge AB's Enterprise Value too high?
Getinge AB's current Enterprise Value is kr71,827 Mil. Overall, Getinge AB has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Getinge AB's Enterprise Value compare to ABT and SYK?
Getinge AB's Enterprise Value of kr71,827 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Getinge AB and its competitors. Getinge AB's current Enterprise Value is kr71,827 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Getinge AB stock overvalued right now?
Based on GuruFocus' analysis, Getinge AB (OSTO:GETI B) is currently considered Modestly Overvalued. The stock's GF Value™ is kr205.32, compared to a current price of kr230.30 — trading 12.2% above its estimated fair value. The current Enterprise Value is kr71,827 Mil. Getinge AB's overall GF Score™ is 81/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Getinge AB (OSTO:GETI B), the current Enterprise Value is kr71,827 Mil as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Getinge AB (OSTO:GETI B) Overvalued in 2026?
Based on GuruFocus' analysis, Getinge AB stock appears to be overvalued.
The current stock price of kr230.30 is trading 12.2% above its estimated GF Value™ of kr205.32.
GuruFocus considers Getinge AB to be Modestly Overvalued.
Key valuation signals for OSTO:GETI B:
Enterprise Value: kr71,827 Mil
GF Value™: kr205.32 vs. price of kr230.30 (12.2% above fair value)
No single metric tells the full story. See the OSTO:GETI B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (35%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales, Europe, Middle East, and Africa 35%, and Asia-Pacific the remaining 25%.
81GF Score
Get the complete analysis for OSTO:GETI B
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:GETI B has been successfully added to your 
